Botanix Pharmaceuticals Limited logo

Botanix Pharmaceuticals Limited

ASX:BOT.AX

Overview | Financials
Company Name Botanix Pharmaceuticals Limited
Symbol BOT.AX
Currency AUD
Price 0.35
Market Cap 636,111,000
Dividend Yield 0%
52-week-range 0.12 - 0.445
Industry Biotechnology
Sector Healthcare
CEO Mr. Vincent P. Ippolito
Website https://www.botanixpharma.com

An error occurred while fetching data.

About Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed

Related Stocks

CleanSpace Holdings Limited logo

CleanSpace Holdings Limited

CSX.AX

0.51 AUD

Doctor Care Anywhere Group PLC logo

Doctor Care Anywhere Group PLC

DOC.AX

0.071 AUD

Invion Limited logo

Invion Limited

IVX.AX

0.002 AUD

Micro-X Limited logo

Micro-X Limited

MX1.AX

0.075 AUD

Biotron Limited logo

Biotron Limited

BIT.AX

0.022 AUD

MedAdvisor Limited logo

MedAdvisor Limited

MDR.AX

0.385 AUD

Emyria Limited logo

Emyria Limited

EMD.AX

0.03 AUD

Universal Biosensors, Inc. logo

Universal Biosensors, Inc.

UBI.AX

0.135 AUD

Orthocell Limited logo

Orthocell Limited

OCC.AX

0.66 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD